Help Bring Your Breakthrough Cancer Treatments To Market Faster

The estimated number of new cancer cases is projected to rise to 28.9 million by 2040. This staggering increase underscores the urgent need for advancements in cancer treatment and research. At Parexel, we believe that by working together, we can create more accessible clinical trials, reduce the need for amendments, boost enrollment, and enhance the overall experience for cancer patients.

Our commitment to accelerating oncology trials in today’s intricate development landscape is unwavering. We achieve faster trial design and execution by leveraging the expertise of our multidisciplinary team, which includes specialists in medical, regulatory, genomics, and biostatistics. This early advisory service ensures that your research is propelled forward efficiently and effectively.

Parexel's extensive experience and strategic technology partnerships empower us to support the development and treatment of all major cancer types across every phase. Our goal is to expedite the journey of your treatment from the research phase to the patient, ensuring that life-saving therapies reach those in need as swiftly as possible. Together, we can make a significant impact in the fight against cancer.